Perceptive Advisors’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding CBIO
OM
Perceptive Advisors's CBIO Position: Q3 2026 in Review
Perceptive Advisors increased its Crescent Biopharma (CBIO) stake by 242% in Q3 2026, buying an estimated $8.38M and bringing the position to 706,942 shares worth $10.3M. The position accounts for 0.18% of the portfolio, ranked #69.
Perceptive Advisors first reported a position in CBIO in Q2 2025 and has held it in 6 quarters since. 104 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.
- Perceptive Advisors held 706,942 shares of Crescent Biopharma worth $10.3M as of Q3 2026.
- Perceptive Advisors bought 500,000 Crescent Biopharma shares in Q3 2026, an estimated $8.38M.
- Crescent Biopharma made up 0.18% of Perceptive Advisors's portfolio in Q3 2026, its #69 holding.
- Perceptive Advisors first reported a position in Crescent Biopharma in Q2 2025 and has held it in 6 quarters since.
- 104 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.
Based on Perceptive Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.